文献速递湿疹皮炎与荨麻疹

特应性皮炎患者哮喘与鼻炎负担及风险的全球估计

Burden and risk of asthma and rhinitis in people with atopic dermatitis: global estimates from a hierarchical Bayesian model.
PubMed 文献 · Br J Dermatol · 2026-01-01

该研究系统检索278项研究,采用贝叶斯分层线性混合效应模型,估计特应性皮炎(AD)患者中哮喘、鼻炎及其亚型的全球患病率与OR值,并比较地区与国家差异。结果显示AD患者哮喘患病率20.1%、鼻炎45.1%,且AD与哮喘(OR 2.73)、鼻炎(OR 2.98)等风险升高相关。

要点

  • AD患者全球哮喘患病率估计为20.1%,鼻炎为45.1%。
  • AD患者合并哮喘的OR为2.73,合并鼻炎的OR为2.98。
  • 患病率估计在印度最高、以色列最低,存在显著地区差异。

核心结论

  • 研究提供首个全球标准化的AD患者呼吸系统共病估计,AD与哮喘、鼻炎及其亚型风险升高相关。
  • 约五分之一AD患者合并哮喘,近半数合并鼻炎,且AD患者发生这些共病的可能性为无AD者的2至4倍。

研究设计与样本

  • 系统综述纳入278项来自PubMed、Embase、Web of Science和CNKI的研究。
  • 采用贝叶斯分层线性混合效应模型推导标准化患病率估计与OR值。

主要发现

  • AD患者全球哮喘患病率估计为20.1%(以色列2.5%至印度59.4%)。
  • 鼻炎患病率为45.1%(以色列7.8%至印度82.7%),过敏性鼻炎为41.4%,鼻结膜炎为30.7%。
  • 哮喘与鼻炎共存的患病率为10.4%(以色列1.1%至印度40.8%)。
  • 与健康对照相比,AD患者哮喘OR为2.73(中国1.59至埃塞俄比亚6.64),鼻炎OR为2.98(中国1.73至埃塞俄比亚7.23)。
  • 过敏性鼻炎OR为2.42,鼻结膜炎OR为4.21(中国2.45至埃塞俄比亚10.19),哮喘与鼻炎共存OR为2.42。

临床怎么用

  • 临床应认识到AD患者中哮喘与鼻炎高发,尤其在印度等高患病率地区。
  • 对AD患者应常规关注呼吸系统共病症状,以便早期识别与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease often associated with asthma and rhinitis. However, epidemiological evidence on these comorbidities remains fragmented and is largely limited to high-income countries. OBJECTIVES: To provide comprehensive global, regional and country-level estimates of the prevalence and odds ratios (ORs) of asthma, rhinitis and their subtypes among individuals with AD. METHODS: We systematically reviewed 278 studies retrieved from PubMed, Embase, Web of Science and CNKI (China National Knowledge Infrastructure). Standardized prevalence estimates and ORs were derived using a Bayesian hierarchical linear mixed-effects model. RESULTS: Among individuals with AD, the global prevalence estimate of asthma, rhinitis, allergic rhinitis, rhinoconjunctivitis, and coexisting asthma and rhinitis was 20.1% (ranging from 2.5% in Israel to 59.4% in India), 45.1% (ranging from 7.8% in Israel to 82.7% in India), 41.4% (ranging from 6.8% in Israel to 80.3% in India), 30.7% (ranging from 4.3% in Israel to 71.9% in India) and 10.4% (ranging from 1.1% in Israel to 40.8% in India), respectively. Estimates were higher when restricted to patients with AD diagnosed by dermatologists or physicians. The highest comorbid prevalence rates were found for India, Cuba, Finland and Puerto Rico. Compared with healthy control individuals, AD was associated with higher odds of asthma (OR 2.73; ranging from 1.59 in China to 6.64 in Ethiopia), rhinitis (OR 2.98; ranging from 1.73 in China to 7.23 in Ethiopia), allergic rhinitis (OR 2.42; ranging from 1.41 in China to 5.89 in Ethiopia), rhinoconjunctivitis (OR 4.21; ranging from 2.45 in China to 10.19 in Ethiopia), and coexisting asthma and rhinitis (OR 2.42; ranging from 1.41 in China to 5.89 in Ethiopia). CONCLUSIONS: This study provides the first globally standardized estimates of respiratory comorbidities in AD, and can inform clinical practice and public health policy. Atopic dermatitis is a common long-term inflammatory skin disease. It is also called eczema. It affects more than 200 million children and adults worldwide. People with the disease often have other conditions, particularly asthma and rhinitis. Asthma affects breathing and rhinitis causes sneezing or congestion. Most studies on these conditions have been in wealthy countries. They have also used a range of different research methods. This makes it difficult to compare and understand the global situation. In this study, researchers in China and the USA analysed data from 278 studies from around the world. We estimated how common asthma and rhinitis are in people with eczema in different regions and countries. We found that about 1 in 5 people with eczema have asthma and almost half have rhinitis. We also found that people with eczema are 2 to 4 times more likely to have these conditions than people without eczema. Some countries showed particularly high rates of these conditions. Our findings suggest that asthma and rhinitis are common problems for people with eczema. This is true no matter where they live. The information from this study may help doctors recognize and manage these conditions in people with eczema. These findings could also support future research to improve disease prevention and patient care.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Ge J, Xu G, et al. Burden and risk of asthma and rhinitis in people with atopic dermatitis: global estimates from a hierarchical Bayesian model. Br J Dermatol. 2026. PMID: 41641462. doi:10.1093/bjd/ljag025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。